Wheeler Bio

Synthace, series C, r&d
Synthace raises $35M Series C to accelerate the development of cures and expand reach
By Pandora Haydon | 05:27 am | November 16, 2021
An R&D cloud platform which supports scientists to share and access progress with the development of biopharmaceutical therapeutics has raised $35 million in investment capital.